SmarterDividends
ABT

Abbott Laboratories

ABT

Healthcare · Stock · quarterly payer

$103.06

Overvalued · -16% Add to Portfolio

Forward Yield

2.45%

Annual Dividend

$2.52

Payout Ratio

79%

5-Yr Growth

10.4%

Ex-Date

Jul 15, 2026

Frequency

Quarterly

Summary

As of July 2026, Abbott Laboratories (ABT) yields 2.45% ($2.52 per share annually), with a blended fair-value estimate of $86.75 — -16% downside, so it screens as overvalued. Dividend safety grade: B (77/100). 12 years of dividend growth.

Is ABT a good dividend stock?

Yes

Abbott Laboratories (ABT) pays a quarterly dividend yielding 2.45% ($2.52/yr), with 12 years of growth and a dividend-safety grade of B. It scores well across payout coverage, growth history and safety — a dependable income holding.

Advantages

  • 12 consecutive years of dividend growth
  • Strong 10.4% 5-yr dividend growth

Risks

  • Cut its dividend in 2013
  • Share price is down over the past 5 years

Key Data

Dividend Yield
2.45%
Payout Ratio
79%
Annual Dividend
$2.52
5-Yr Avg Growth
10.4%
Ex-Dividend Date
Jul 15, 2026
Years of Growth
12
Frequency
quarterly
Beta
0.61
Market Cap
$179.5B
P/E Ratio
33.4
5-Yr Total Return
-18%
52-Week Range
$81.97 – $137.49
Dividend Safety
B · 77/100
Ever Cut?
Yes (2013)
ABT ex-dividend date & scheduleNext ex-date Jul 15, 2026 · full ex-dividend historyView →

Frequently Asked Questions

Income Calculator

At $2.52 / yr per share

Per payment (quarterly)$63.00
Annual$252.00
Monthly avg$21.00